Target Audience and Goal Statement
This activity is intended for allergists, pulmonologists, and primary care physicians.
The goals of this activity are to increase awareness of benefits of long-term prophylaxis for hereditary angioedema (HAE)
and treatment options.
Upon completion of this activity, participants will:
- Have increased knowledge regarding the
- Treatment options for long-term prophylaxis of HAE attacks
- Have greater competence related to
- Selecting among HAE prophylaxis options based on goals of therapy
- Patient-centric considerations for short- and long-term HAE prophylaxis
Disclosures
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of
an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant
financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial
relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food
and Drug Administration, at first mention and where appropriate in the content.
Moderator

-
Marc A. Riedl, MD, MS
Professor of Medicine, Clinical Director, US HAEA Angioedema Center, Training Program Director , Division of Rheumatology,
Allergy and Immunology, University of California, San Diego, La Jolla, California
Disclosures
Disclosure: Marc A. Riedl, MD, MS, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Adverum Biotechnologies; Alnylam Pharmaceuticals, Inc.; BioCryst Pharmaceuticals,
Inc.; CSL Behring; Ionis Pharmaceuticals, Inc.; KalVista Pharmaceuticals; Pharming Group NV; Shire
Served as a speaker or a member of a speakers bureau for: CSL Behring; Pharming Group NV; Shire
Received grants for clinical research from: BioCryst Pharmaceuticals, Inc.; CSL Behring; Ionis Pharmaceuticals, Inc.; Pharming
Group NV; Shire
Dr Riedl does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA
for use in the United States.
Dr Riedl does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA
for use in the United States.
Panelists

-
Timothy Craig, DO
Professor of Medicine and Pediatrics, Distinguished Educator, Program Director, Section Chief, Director of Clinical Allergy,
Immunology and Respiratory Research; Director of Alpha-1-Deficiency Center, Vietnam Education Foundation Scholar, Penn State
University, Hershey, Pennsylvania
Disclosures
Disclosure: Timothy Craig, DO, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: BioCryst Pharmaceuticals, Inc.; CSL Behring
Served as a speaker or a member of a speakers bureau for: CSL Behring; Grifols
Received grants for clinical research from: BioCryst Pharmaceuticals, Inc.; CSL Behring; Grifols; Shire
Dr Craig does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the
FDA for use in the United States.
Dr Craig does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the
FDA for use in the United States.

-
William R. Lumry, MD
Clinical Professor of Internal Medicine, Division of Allergy and Immunology, University of Texas Southwestern Medical School;
Medical Director, AARA Research Center; Private Practice, Dallas, Texas
Disclosures
Disclosure: William R. Lumry, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: BioCryst Pharmaceuticals, Inc.; CSL Behring; Pharming Group NV; Shire
Served as a speaker or a member of a speakers bureau for: CSL Behring; Pharming Group NV; Shire
Dr Lumry does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the
FDA for use in the United States.
Dr Lumry does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the
FDA for use in the United States.
Editor
CME Reviewer
Peer Reviewer
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
Accreditation Statements
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical
Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC),
to provide continuing education for the healthcare team.
For Physicians
-
Medscape, LLC designates this enduring material for a maximum of 0.50
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Contact This Provider
For questions regarding the content of this activity, contact the
accredited provider for this CME/CE activity noted above. For technical
assistance, contact [email protected]
Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
- Read the target audience, learning objectives, and author disclosures.
- Study the educational content online or printed out.
- Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated
at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.